Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,019 | 99,915 | 331,549 | 36,269 | 54,004 |
| Marketable Securities | 826,232 | 534,216 | 27,225 | 234,077 | 230,145 |
| Receivables | 53,822 | N/A | N/A | N/A | N/A |
| Inventories | 34,068 | 0 | N/A | N/A | N/A |
| TOTAL | $1,032,927 | $637,281 | $361,369 | $271,684 | $285,163 |
| Non-Current Assets | |||||
| PPE Net | 2,190 | 1,553 | 601 | 851 | 1,047 |
| Intangibles | 4,729 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,401 | 1,713 | 602 | 797 | 785 |
| TOTAL | $9,320 | $3,266 | $1,203 | $1,648 | $1,832 |
| Total Assets | $1,042,247 | $640,547 | $362,572 | $273,332 | $286,995 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 43,599 | 28,041 | 23,831 | 21,380 | 1,017 |
| Accrued Expenses | 124,695 | 89,980 | 91,461 | 55,048 | 45,222 |
| TOTAL | $169,277 | $118,548 | $115,894 | $76,838 | $46,557 |
| Non-Current Liabilities | |||||
| Long Term Debt | 117,569 | 115,480 | 49,289 | N/A | N/A |
| Other Non-Current Liabilities | 1,018 | 1,186 | 0 | 387 | 468 |
| TOTAL | $118,587 | $116,666 | $49,289 | $387 | $468 |
| Total Liabilities | $287,864 | $235,214 | $165,183 | $77,225 | $47,025 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,080 | 19,897 | 18,138 | 17,103 | 16,025 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,802,182 | -1,336,290 | -962,660 | -667,310 | -425,464 |
| Other shareholders' equity | 468 | 468 | -32 | -80 | 47 |
| TOTAL | $754,383 | $405,333 | $197,389 | $196,107 | $239,970 |
| Total Liabilities And Equity | $1,042,247 | $640,547 | $362,572 | $273,332 | $286,995 |